Use of novel haptens in the production of antibodies for the detection of tryptamines.
RSC advances April 27, 2018 Michal Maryška, Lucie Fojtíková, Radek Jurok et al.
Polyclonal antibodies produced in rabbits against novel haptens derived from tryptamine-based drugs—DMT, 5-MeO-DMT, and DiPT—show good reactivity and low detection limits (0.006-0.254 ng mL-1) in ELISAs, making them suitable for developing immunochemical assay kits to simplify detection of these hallucinogenic drugs in body fluids.